article thumbnail

How can real-world evidence support regulatory decision making?

European Pharmaceutical Review

Additionally, studies to inform the design and feasibility of clinical trials and clinical management were appraised too. Also, the report identified that tools to further build capability and capacity for RWE generation and close collaboration with decision-makers and other stakeholders are also needed.

article thumbnail

What HCPs think about COVID-19’s impact on cancer

pharmaphorum

For the pharmaceutical industry, this knowledge could help teams in their communication plans to support HCPs with updated information or guidelines about treatments. — Aditya Bardia, MD (@ABhealer108) March 14, 2020. noeasychoices #inthetimesofcoronavirus #lcsm @HemOncWomenDocs pic.twitter.com/kVTle1JWtI.

Hospitals 124
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UK-wide whole genome sequencing for newborns is feasible – but there are some key questions to answer first

pharmaphorum

Instead, it would represent a support to the existing screening programme by offering a deeper level of information on the conditions that biochemical testing identifies. clinical management of the condition must be optimised in all healthcare providers. These include: the condition screened for must be adequately understood.

Hospitals 116
article thumbnail

Welcome to the COVIDome, a new tool for COVID-19 R&D

pharmaphorum

Take a cohort of people hospitalised with COVID-19 and a group of negative controls, carry out extensive biological profiling of both groups and place all the information in a database. What do you get?

article thumbnail

The Incredible Shrinking Exemption: FDA Final CDS Guidance Would Significantly Narrow the Scope of Exempt Clinical Decision Support Software Under the Cures Act

The FDA Law Blog

Criterion 2 : Non-Device CDS software functions display, analyze or print medical information about a patient or other medical information. Here again, FDA’s novel interpretation of statutory terms effectively narrows the scope of information that a software product can display, analyze, or print and still be considered Non-Device CDS.

FDA 52
article thumbnail

Leading speciality pharmacies in pharma

Pharmaceutical Technology

Clinical interventions, and psychosocial and emotional assessment. The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision. . · Prescription refill and renewal. Prior authorisation assistance. Patient advocate support, and.

article thumbnail

How to Improve Communication between Patient and Doctor?

Viseven

Keeping information secret Clinical results might be significantly impacted if patients do not fully comprehend their health condition or treatment options. A healthy patient-physician relationship depends on doctors delivering information clearly and compassionately. Inform the patient if the schedule changes.